{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:13:40Z","timestamp":1774930420063,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,21]]},"DOI":"10.7759\/cureus.35264","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T16:34:22Z","timestamp":1676997262000},"source":"Crossref","is-referenced-by-count":7,"title":["Amyloidosis of the Heart: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Urooj","family":"Imdad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","author":"Dubrey SW","year":"1998","unstructured":"Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM. 1998, 91:141-57. 10.1093\/qjmed\/91.2.141","journal-title":"QJM"},{"key":"ref2","article-title":"Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management","volume":"32","author":"Hassan W","year":"2005","unstructured":"Hassan W, Al-Sergani H, Mourad W, Tabbaa R. Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management. Tex Heart Inst J. 2005, 32:178-84.","journal-title":"Tex Heart Inst J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.17.1805","article-title":"Amyloidosis and the heart: a comprehensive review","volume":"166","author":"Shah KB","year":"2006","unstructured":"Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med. 2006, 166:1805-13. 10.1001\/archinte.166.17.1805","journal-title":"Arch Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2012.684810","article-title":"New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis","volume":"19","author":"Leone O","year":"2012","unstructured":"Leone O, Longhi S, Quarta CC, et al.. New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis. Amyloid. 2012, 19:99-105. 10.3109\/13506129.2012.684810","journal-title":"Amyloid"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-2-200401200-00008","article-title":"High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study","volume":"140","author":"Skinner M","year":"2004","unstructured":"Skinner M, Sanchorawala V, Seldin DC, et al.. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med. 2004, 140:85-93. 10.7326\/0003-4819-140-2-200401200-00008","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plant\u00e9-Bordeneuve V","year":"2011","unstructured":"Plant\u00e9-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol. 2011, 10:1086-97. 10.1016\/S1474-4422(11)70246-0","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20821","article-title":"The molecular biology and clinical features of amyloid neuropathy","volume":"36","author":"Benson MD","year":"2007","unstructured":"Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve. 2007, 36:411-23. 10.1002\/mus.20821","journal-title":"Muscle Nerve"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-014-9462-7","article-title":"Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs","volume":"20","author":"Casta\u00f1o A","year":"2015","unstructured":"Casta\u00f1o A, Drachman BM, Judge D, Maurer MS. Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs. Heart Fail Rev. 2015, 20:163-78. 10.1007\/s10741-014-9462-7","journal-title":"Heart Fail Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702133360703","article-title":"Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans","volume":"336","author":"Jacobson DR","year":"1997","unstructured":"Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med. 1997, 336:466-73. 10.1056\/NEJM199702133360703","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.12.1425","article-title":"Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis","volume":"165","author":"Ng B","year":"2005","unstructured":"Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med. 2005, 165:1425-9. 10.1001\/archinte.165.12.1425","journal-title":"Arch Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)90443-6","article-title":"Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation","volume":"75","author":"Cornwell GG 3rd","year":"1983","unstructured":"Cornwell GG 3rd, Murdoch WL, Kyle RA, Westermark P, Pitk\u00e4nen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med. 1983, 75:618-23. 10.1016\/0002-9343(83)90443-6","journal-title":"Am J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701233360407","article-title":"Restrictive cardiomyopathy","volume":"336","author":"Kushwaha SS","year":"1997","unstructured":"Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med. 1997, 336:267-76. 10.1056\/NEJM199701233360407","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197507000-00001","article-title":"Amyloidosis: review of 236 cases","volume":"54","author":"Kyle RA","year":"1975","unstructured":"Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine (Baltimore). 1975, 54:271-99. 10.1097\/00005792-197507000-00001","journal-title":"Medicine (Baltimore)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4950250109","article-title":"Cardiac amyloidosis presenting with elevations of cardiac troponin I and angina pectoris","volume":"25","author":"Cantwell RV","year":"2002","unstructured":"Cantwell RV, Aviles RJ, Bjornsson J, et al.. Cardiac amyloidosis presenting with elevations of cardiac troponin I and angina pectoris. Clin Cardiol. 2002, 25:33-7. 10.1002\/clc.4950250109","journal-title":"Clin Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi C","year":"2009","unstructured":"Rapezzi C, Merlini G, Quarta CC, et al.. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation. 2009, 120:1203-12. 10.1161\/CIRCULATIONAHA.108.843334","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk RH","year":"2005","unstructured":"Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005, 112:2047-60. 10.1161\/CIRCULATIONAHA.104.489187","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2009.190405","article-title":"Amyloid diseases of the heart: assessment, diagnosis, and referral","volume":"97","author":"Dubrey SW","year":"2011","unstructured":"Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart. 2011, 97:75-84. 10.1136\/hrt.2009.190405","journal-title":"Heart"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(97)00267-2","article-title":"Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement","volume":"30","author":"Reisinger J","year":"1997","unstructured":"Reisinger J, Dubrey SW, Lavalley M, Skinner M, Falk RH. Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. J Am Coll Cardiol. 1997, 30:1046-51. 10.1016\/s0735-1097(97)00267-2","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(97)82785-3","article-title":"Symptomatic conduction system disease in cardiac amyloidosis","volume":"80","author":"Mathew V","year":"1997","unstructured":"Mathew V, Olson LJ, Gertz MA, Hayes DL. Symptomatic conduction system disease in cardiac amyloidosis. Am J Cardiol. 1997, 80:1491-2. 10.1016\/s0002-9149(97)82785-3","journal-title":"Am J Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.697763","article-title":"Intracardiac thrombosis and embolism in patients with cardiac amyloidosis","volume":"116","author":"Feng D","year":"2007","unstructured":"Feng D, Edwards WD, Oh JK, et al.. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation. 2007, 116:2420-6. 10.1161\/CIRCULATIONAHA.107.697763","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-6196(12)60388-7","article-title":"Familial amyloidosis: a study of 52 North American-born patients examined during a 30-year period","volume":"67","author":"Gertz MA","year":"1992","unstructured":"Gertz MA, Kyle RA, Thibodeau SN. Familial amyloidosis: a study of 52 North American-born patients examined during a 30-year period. Mayo Clin Proc. 1992, 67:428-40. 10.1016\/s0025-6196(12)60388-7","journal-title":"Mayo Clin Proc"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.78.1.74","article-title":"Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes","volume":"78","author":"Dubrey SW","year":"1997","unstructured":"Dubrey SW, Cha K, Skinner M, LaValley M, Falk RH. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart. 1997, 78:74-82. 10.1136\/hrt.78.1.74","journal-title":"Heart"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.91.4.962","article-title":"A novel variant of transthyretin, 59Thr\u2192Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family","volume":"91","author":"Booth DR","year":"1995","unstructured":"Booth DR, Tan SY, Hawkins PN, Pepys MB, Frustaci A. A novel variant of transthyretin, 59Thr\u2192Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family. Circulation. 1995, 91:962-7. 10.1161\/01.cir.91.4.962","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3109\/13506120208995246","article-title":"Identification of a novel transthyretin Thr59Lys\/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis","volume":"9","author":"Lim A","year":"2002","unstructured":"Lim A, Prokaeva T, Connor LH, Falk RH, Skinner M, Costello CE. Identification of a novel transthyretin Thr59Lys\/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis. Amyloid. 2002, 9:134-40. 10.3109\/13506120208995246","journal-title":"Amyloid"},{"key":"ref25","article-title":"Hereditary ATTR amyloidosis: burden of illness and diagnostic challenges","volume":"23","author":"Gertz MA","year":"2017","unstructured":"Gertz MA. Hereditary ATTR amyloidosis: burden of illness and diagnostic challenges. Am J Manag Care. 2017, 23:S107-12.","journal-title":"Am J Manag Care"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000034511.06350.df","article-title":"Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation","volume":"106","author":"R\u00f6cken C","year":"2002","unstructured":"R\u00f6cken C, Peters B, Juenemann G, et al.. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation. 2002, 106:2091-7. 10.1161\/01.cir.0000034511.06350.df","journal-title":"Circulation"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.10.028","article-title":"Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement","volume":"95","author":"Murtagh B","year":"2005","unstructured":"Murtagh B, Hammill SC, Gertz MA, Kyle RA, Tajik AJ, Grogan M. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol. 2005, 95:535-7. 10.1016\/j.amjcard.2004.10.028","journal-title":"Am J Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar S","year":"2012","unstructured":"Kumar S, Dispenzieri A, Lacy MQ, et al.. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012, 30:989-95. 10.1200\/JCO.2011.38.5724","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri A","year":"2004","unstructured":"Dispenzieri A, Gertz MA, Kyle RA, et al.. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol. 2004, 22:3751-7. 10.1200\/JCO.2004.03.029","journal-title":"J Clin Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13396-X","article-title":"Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins","volume":"361","author":"Dispenzieri A","year":"2003","unstructured":"Dispenzieri A, Kyle RA, Gertz MA, et al.. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet. 2003, 361:1787-9. 10.1016\/S0140-6736(03)13396-X","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.08.028","article-title":"Evaluation and management of the cardiac amyloidosis","volume":"50","author":"Selvanayagam JB","year":"2007","unstructured":"Selvanayagam JB, Hawkins PN, Paul B, Myerson SG, Neubauer S. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol. 2007, 50:2101-10. 10.1016\/j.jacc.2007.08.028","journal-title":"J Am Coll Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90948-9","article-title":"Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis","volume":"59","author":"Falk RH","year":"1987","unstructured":"Falk RH, Plehn JF, Deering T, et al.. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol. 1987, 59:418-22. 10.1016\/0002-9149(87)90948-9","journal-title":"Am J Cardiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.08.043","article-title":"Noninvasive diagnosis of biopsy-proven cardiac amyloidosis","volume":"43","author":"Rahman JE","year":"2004","unstructured":"Rahman JE, Helou EF, Gelzer-Bell R, et al.. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol. 2004, 43:410-5. 10.1016\/j.jacc.2003.08.043","journal-title":"J Am Coll Cardiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.63.1.188","article-title":"M-mode and two-dimensional echocardiographic features in cardiac amyloidosis","volume":"63","author":"Siqueira-Filho AG","year":"1981","unstructured":"Siqueira-Filho AG, Cunha CL, Tajik AJ, Seward JB, Schattenberg TT, Giuliani ER. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation. 1981, 63:188-96. 10.1161\/01.cir.63.1.188","journal-title":"Circulation"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(83)80139-8","article-title":"Myocardial texture characterization by two-dimensional echocardiography","volume":"51","author":"Bhandari AK","year":"1983","unstructured":"Bhandari AK, Nanda NC. Myocardial texture characterization by two-dimensional echocardiography. Am J Cardiol. 1983, 51:817-25. 10.1016\/s0002-9149(83)80139-8","journal-title":"Am J Cardiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004","volume":"79","author":"Gertz MA","year":"2005","unstructured":"Gertz MA, Comenzo R, Falk RH, et al.. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005, 79:319-28. 10.1002\/ajh.20381","journal-title":"Am J Hematol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060225","article-title":"Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis","volume":"13","author":"Hamer JP","year":"1992","unstructured":"Hamer JP, Janssen S, van Rijswijk MH, Lie KI. Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis. Eur Heart J. 1992, 13:623-7. 10.1093\/oxfordjournals.eurheartj.a060225","journal-title":"Eur Heart J"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(82)90270-3","article-title":"Amyloid cardiomyopathy: characterization by a distinctive voltage\/mass relation","volume":"49","author":"Carroll JD","year":"1982","unstructured":"Carroll JD, Gaasch WH, McAdam KP. Amyloid cardiomyopathy: characterization by a distinctive voltage\/mass relation. Am J Cardiol. 1982, 49:9-13. 10.1016\/0002-9149(82)90270-3","journal-title":"Am J Cardiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000068313.67758.4F","article-title":"Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis","volume":"107","author":"Koyama J","year":"2003","unstructured":"Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation. 2003, 107:2446-52. 10.1161\/01.CIR.0000068313.67758.4F","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2015.05.014","article-title":"Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis","volume":"9","author":"Ternacle J","year":"2016","unstructured":"Ternacle J, Bodez D, Guellich A, et al.. Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis. JACC Cardiovasc Imaging. 2016, 9:126-38. 10.1016\/j.jcmg.2015.05.014","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira AM","year":"2005","unstructured":"Maceira AM, Joshi J, Prasad SK, et al.. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005, 111:186-93. 10.1161\/01.CIR.0000152819.97857.9D","journal-title":"Circulation"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(98)00998-9","article-title":"Assessment of restrictive cardiomyopathy of amyloid or idiopathic etiology by magnetic resonance imaging","volume":"83","author":"Celletti F","year":"1999","unstructured":"Celletti F, Fattori R, Napoli G, Leone O, Rocchi G, Reggiani LB, Gavelli G. Assessment of restrictive cardiomyopathy of amyloid or idiopathic etiology by magnetic resonance imaging. Am J Cardiol. 1999, 83:798-801, A10. 10.1016\/s0002-9149(98)00998-9","journal-title":"Am J Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-016-0311-6","article-title":"Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis","volume":"16","author":"Zhao L","year":"2016","unstructured":"Zhao L, Tian Z, Fang Q. Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2016, 16:129. 10.1186\/s12872-016-0311-6","journal-title":"BMC Cardiovasc Disord"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2009.08.008","article-title":"Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis","volume":"2","author":"Austin BA","year":"2009","unstructured":"Austin BA, Tang WH, Rodriguez ER, et al.. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging. 2009, 2:1369-77. 10.1016\/j.jcmg.2009.08.008","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.09.105","article-title":"Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis","volume":"103","author":"Ruberg FL","year":"2009","unstructured":"Ruberg FL, Appelbaum E, Davidoff R, et al.. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol. 2009, 103:544-9. 10.1016\/j.amjcard.2008.09.105","journal-title":"Am J Cardiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2011.08.013","article-title":"Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases","volume":"4","author":"Zou Z","year":"2011","unstructured":"Zou Z, Zhang HL, Roditi GH, Leiner T, Kucharczyk W, Prince MR. Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases. JACC Cardiovasc Imaging. 2011, 4:1206-16. 10.1016\/j.jcmg.2011.08.013","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12511","article-title":"Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis","volume":"6","author":"Brownrigg J","year":"2019","unstructured":"Brownrigg J, Lorenzini M, Lumley M, Elliott P. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis. ESC Heart Fail. 2019, 6:1041-51. 10.1002\/ehf2.12511","journal-title":"ESC Heart Fail"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13025","article-title":"Outcomes after heart transplantation for amyloid cardiomyopathy in the modern era","volume":"15","author":"Davis MK","year":"2015","unstructured":"Davis MK, Kale P, Liedtke M, et al.. Outcomes after heart transplantation for amyloid cardiomyopathy in the modern era. Am J Transplant. 2015, 15:650-8. 10.1111\/ajt.13025","journal-title":"Am J Transplant"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer MS","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B, et al.. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018, 379:1007-16. 10.1056\/NEJMoa1805689","journal-title":"N Engl J Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181ac60db","article-title":"Combined heart and liver transplantation: a single-center experience","volume":"88","author":"Raichlin E","year":"2009","unstructured":"Raichlin E, Daly RC, Rosen CB, et al.. Combined heart and liver transplantation: a single-center experience. Transplantation. 2009, 88:219-25. 10.1097\/TP.0b013e3181ac60db","journal-title":"Transplantation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/40909-amyloidosis-of-the-heart-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:48Z","timestamp":1707508308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/40909-amyloidosis-of-the-heart-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.35264","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,21]]}}}